导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.19% | 385/982 |
| 近一周 | -0.70% | 378/1031 |
| 近一月 | -7.33% | 905/1030 |
| 近一季 | 17.46% | 47/1021 |
| 近半年 | 6.26% | 293/1001 |
| 近一年 | -17.36% | 797/953 |
| 近两年 | 45.21% | 513/874 |
| 近三年 | 32.96% | 358/786 |
| 成立以来 | 89.65% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.72% 157/1070 |
-1.52% 726/1101 |
- - |
- - |
| 2025 | 33.92% 416/1065 |
17.89% 36/1014 |
17.10% 28/1038 |
22.67% 516/1050 |
-20.91% 1036/1065 |
| 2024 | -11.44% 795/1011 |
-3.71% 516/960 |
-1.17% 387/983 |
4.36% 900/991 |
-10.82% 925/1011 |
| 2023 | 6.23% 38/952 |
8.15% 168/880 |
-1.65% 281/895 |
-1.92% 153/915 |
1.82% 70/952 |
| 2022 | -17.10% 226/867 |
-12.82% 171/773 |
2.24% 660/806 |
-12.67% 437/845 |
6.51% 148/867 |
| 2021 | -9.33% 480/740 |
-3.45% 280/580 |
27.40% 63/659 |
-14.59% 599/704 |
-13.71% 678/740 |
| 2020 | 79.71% 92/554 |
22.10% 5/419 |
44.01% 12/466 |
-0.05% 420/517 |
2.25% 473/554 |
| 2019 | 72.81% 28/410 |
32.99% 216/1146 |
4.02% 76/1228 |
17.94% 23/390 |
5.92% 312/410 |
| 2018 | -33.56% 257/349 |
- - |
-1.57% 107/990 |
-14.49% 938/1000 |
-21.38% 995/1080 |
| 2017 | 16.57% 94/285 |
- - |
- - |
- - |
- - |
| 2016 | -14.05% 85/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 宝盈医疗健康沪港深股票A VS. 东吴新产业精选股票A(580008) |